While the majority of studies focused on the role of NDRG1 in various oncogenic signaling pathways in cancer, more recent work has revealed that this metastasis suppressor also influences metabolic reprogramming of cancer cells, disrupts lipid synthesis, regulates intracellular trafficking and degradation mechanisms, and impacts the TME. The gene discussed is NDRG1; the disease is cancer.